FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 365 participants.
Also called NCT01071122
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 365 participants
- Sponsor
- Registry
-
NCT01071122
-
- Other papers using this trial's data
- Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS Study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT01071122. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2012-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)
- Condition
- Hypertension
- Intervention (Drug)
- Nifedipine (Adalat, BAYA1040) and Valsartan
- Intervention (Drug)
- Nifedipine (Adalat, BAYA1040)
- Intervention (Drug)
- Valsartan
- Lead sponsor
- Bayer
Record details
- Record id
cardio:ct-nct01071122- Content hash
1f621a44b5c55d254562bd7f2afdccba94037adecc2376336a5e06f2927b1ec8